Vanguard Group Inc Cara Therapeutics, Inc. Call Options Transaction History
Vanguard Group Inc
- $4.96 Trillion
- Q1 2024
Call Options
0 transactions
Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
---|
Others Institutions Holding CARA
# of Institutions
102Shares Held
21.5MCall Options Held
50KPut Options Held
0-
Black Rock Inc. New York, NY3.42MShares$1.13 Million0.0% of portfolio
-
Disciplined Growth Investors Inc Minneapolis, MN1.82MShares$598,9690.03% of portfolio
-
Chescapmanager LLC Baltimore, MD1.7MShares$561,6960.15% of portfolio
-
Farallon Capital Management LLC San Francisco, CA1.56MShares$513,5620.01% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny1.33MShares$439,7170.0% of portfolio
About Cara Therapeutics, Inc.
- Ticker CARA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 53,725,900
- Market Cap $17.7M
- Description
- Cara Therapeutics, Inc., an early commercial-stage biopharmaceutical company, focuses on developing and commercializing chemical entities with a primary focus on pruritus and pain by selectively targeting kappa opioid receptors in the United States. The company is developing product candidates that target the body's peripheral nervous system and...